Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GENB
NTLA
Add up to 3 more stocks
GENB
Generate Biomedicines, Inc.
-1.42%
$13.71-0.20Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$1.76B
52W Range
$11.00 - $22.67
NTLA
Intellia Therapeutics, Inc.
-3.92%
$12.25-0.50Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$1.71B
52W Range
$7.95 - $28.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.85 | 2.35 |
| P/S Ratio | N/A | 28.76 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 76.5% |
| Operating Margin | -737.0% | -651.7% |
| Net Margin | -637.0% | -672.2% |
| ROE | N/A | -55.0% |
| ROA | -61.5% | -46.7% |
| ROIC | -94.8% | -54.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 8.30 | 6.65 |
| Quick Ratio | 8.30 | 6.65 |
| Debt/Equity | 0.14 | 0.10 |
| Interest Coverage | -206.92 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.